Earnings Per Share, Basic in USD/shares of Aquestive Therapeutics, Inc. from Q2 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Aquestive Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q2 2018 to Q3 2025.
  • Aquestive Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.14 USD/shares, a 7.69% decline year-over-year.
  • Aquestive Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was 0 USD/shares, a 45.8% decline year-over-year.
  • Aquestive Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -0.51 USD/shares, a 292% decline from 2023.
  • Aquestive Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.13 USD/shares, a 88.4% increase from 2022.
  • Aquestive Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1.12 USD/shares, a 39.5% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Aquestive Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0 $0 -7.69% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $0 $0 $0 -367% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $0 $0 $0 -41.2% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q4 2024 $0 $0 $0 -20% 01 Oct 2024 31 Dec 2024 10-K 05 Mar 2025
Q3 2024 $0 $0 $0 -333% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 $0 $0 +$0.07 +70% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 $0 $0 $0 -213% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025
Q4 2023 $0 $0 +$0.06 +28.6% 01 Oct 2023 31 Dec 2023 10-K 05 Mar 2025
Q3 2023 $0 $0 +$0.20 +87% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024
Q2 2023 $0 $0 +$0.26 +72.2% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 $0 $0.15 +$0.47 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 -$1 $0 +$0.53 +71.6% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 -$1 $0 +$0.14 +37.8% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 -$1 $0 $0 -9.09% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 -$1 $0 +$0.09 +22% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023
Q4 2021 -$1 -$1 $0 -21.3% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$1 $0 +$0.12 +24.5% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022
Q2 2021 -$1 $0 $0 -371% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022
Q1 2021 -$1 $0 +$0.08 +16.3% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 -$1 -$1 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2022
Q3 2020 $0 +$0.25 +33.8% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021
Q2 2020 $0 +$0.75 +91.5% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021
Q1 2020 $0 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021
Q3 2019 -$1 $0 -15.6% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 -$1 +$1.08 +56.8% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2019
Q3 2018 -$1 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019
Q2 2018 -$2 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019

Aquestive Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1 $0 -292% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2025
2023 $0 +$0.99 +88.4% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2025
2022 -$1 +$0.73 +39.5% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024
2021 -$2 $0 -11.4% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$2 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.